• Neurizon Therapeutics requests trading halt pending announcement on proposed capital raising
• Trading halt to remain in place until earlier of market open on Dec 23 or announcement release
• Company expects to make announcement before market open on Dec 23

Neurizon Therapeutics Limited (ASX: NUZ) has requested an immediate halt to the trading of the company's ordinary shares and listed options (NUZ and NUZOA) on the Australian Securities Exchange (ASX). The trading halt is requested pending an announcement by the company to the market regarding the outcome of a proposed capital raising. The trading halt will remain in place until the earlier of the commencement of normal trading on Tuesday, 23 December 2025, or when the announcement regarding the capital raising is released to the market. The company expects to make the announcement regarding the capital raising before the commencement of normal trading on Tuesday, 23 December 2025. Neurizon Therapeutics has stated that the trading halt is necessary to assist the company in managing its continuous disclosure obligations as it expects to make an announcement to the market in relation to the proposed capital raising.